Trials / Completed
CompletedNCT05993806
A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers
A Randomized, Open-label, Single-dose, Two-sequence, Two-period, Cross-over Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of L04TD3 and L04RD1 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Celltrion · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open, single-dose, crossover-design, phase 1, singlecenter study to evaluate bioequivalence after administration of L04RD1 or administration of L04TD3 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L04RD1 | 1 tablet of L04RD1 |
| DRUG | L04TD3 | 1 tablet of L04TD3 |
Timeline
- Start date
- 2023-06-02
- Primary completion
- 2023-06-12
- Completion
- 2023-06-29
- First posted
- 2023-08-15
- Last updated
- 2023-08-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05993806. Inclusion in this directory is not an endorsement.